Application no. and date | 18150968.8 (espacenet) (Federated) (European Patent Register), 20120502 | Patent/reg. no. and date | DK/EP 3329965, 20250319 | Publication date | 20180606 | Priority no. and date | US 201161481533 P, 20110502, US 201161550545 P, 20111024, US 201261585859 P, 20120112 | EP pub. no. and date |
EP 3329965 20180606 | Effective date | | Applicant/owner | Millennium Pharmaceuticals, Inc., 40 Landsdowne Street
Cambridge, MA 02139, US | Applicant ref. no. | P86191DK01 | Inventor | Palaniappan, Vaithianathan, 7 Spruce Circle
Andover, MA 01810, US, VARGA, Csanad M., 83 Commonwealth Park W
Newton, MA 02459, US, DILUZIO, Willow, 31 Castle View Drive
Gloucester, MA 01930, US, TRUONG, Nobel T., 26 Stailbrook Road
Milford, MA 01757, US, BROWN, Jason, 10 September Lane
Burlington, MA 01803, US, FOX, Irving H., 111 Livingston Road
Wellesley, MA 02482, US, SCHOLZ, Catherine, 1 Nashua Street
Woburn, MA 01801, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) , A61K 9/19 (2006.01) , A61P 1/00 (2006.01) , C07K 16/28 (2006.01) | Title | DOSERINGSREGIME FOR ANTI-ALPHA4BETA7-ANTISTOF | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|